Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

385.16 -2.48 (-0.64%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗

December 23, 2025

Via Stocktwits

Topics Government

SCHD vs. NOBL: Different Paths to Dividend Stability ↗

December 22, 2025

Both ETFs target dividend paying stocks, but their rules determine whether investors receive higher income or stricter dividend consistency

Via The Motley Fool

Topics ETFs

Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers

December 21, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Biogen (NASDAQ:BIIB) and its peers.

Via StockStory

Topics Artificial Intelligence

Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗

December 19, 2025

The deals expand the pricing program to most targeted drugmakers in exchange for temporary tariff relief.

Via Stocktwits

Topics Government World Trade

The Great Biotech Re-Shoring: Seres Therapeutics and the New Commodity-Driven Era

December 19, 2025

As the final weeks of 2025 unfold, the biotechnology sector is undergoing a fundamental transformation, shifting from a pure-play innovation market to one increasingly dictated by the "physical"...

Via MarketMinute

Topics Earnings Economy Intellectual Property

This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗

December 19, 2025

This top-shelf exchange-traded fund (ETF) checks all the right boxes for income- and value-seeking investors.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗

December 17, 2025

The potential agreements would mark another step in Washington’s broader effort to reshape drug pricing.

Via Stocktwits

Topics Government World Trade

Investors Rotate Out of Big Tech and AI: A Market Reassessment Underway

December 17, 2025

As late 2025 draws to a close, a significant recalibration is underway in global financial markets, with investors increasingly rotating capital away from the once-dominant Big Tech and Artificial...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026? ↗

December 16, 2025

Each company has a bullish case, but three stand out as great long-term buys.

Via The Motley Fool

Topics Bonds Economy Intellectual Property

“Buying the Dip” in 2025: A Strategy Rewarded, But Future Requires Caution and Diversification

December 16, 2025

December 16, 2025 – The "buying the dip" investment strategy, which involves purchasing an asset after its price has declined with the anticipation of a subsequent recovery, has seen significant...

Via MarketMinute

Topics Artificial Intelligence Economy

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most ↗

December 16, 2025

Via MarketBeat

7 Dividend ETFs to Buy With $2,000 and Hold Forever -- Including the Schwab U.S. Dividend Equity ETF (SCHD) ↗

December 15, 2025

It's hard to beat dividend-paying stocks -- in part because they tend to increase their payouts regularly.

Via The Motley Fool

Topics ETFs

1 Dow Jones Stock Worth Your Attention and 2 We Brush Off

December 14, 2025

The Dow Jones (^DJI) is made up of 30 of the most established and influential companies in the market. But even blue-chip stocks can struggle - some are dealing with slowing growth, outdated business...

Via StockStory

Topics Stocks

2 Dividend Stocks to Double Up on Right Now ↗

December 14, 2025

These dividend growth machines could have considerable upside for long-term investors.

Via The Motley Fool

Topics Economy Intellectual Property

Manufacturing Renaissance Fuels Job Market Amidst Shifting Sands

December 09, 2025

The American labor market is experiencing a fascinating dichotomy as it navigates late 2024 and 2025. While overall job creation has shown signs of moderation and significant revisions to earlier...

Via MarketMinute

Topics Artificial Intelligence Economy Electric Vehicles

2 Momentum Stocks for Long-Term Investors and 1 We Brush Off

December 07, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

Gapping S&P500 stocks in Friday's session ↗

December 05, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.

Via Chartmill

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

Via Investor Brand Network

Topics Government

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

From BioMedWire

Via GlobeNewswire

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

These ETFs can provide me with lots of passive income.

Via The Motley Fool

Topics ETFs Stocks

Janux Therapeutics Craters 50% On Prostate Cancer Update; Is It An 'Overreaction'? ↗

December 02, 2025

Shares crashed Tuesday on what one analyst called an "overreaction" to the company's prostate cancer treatment update.

Via Investor's Business Daily

2 Dividend Stocks to Double Up On Right Now ↗

December 01, 2025

Investors don't have to worry about dividend cuts with these two stocks.

Via The Motley Fool

Topics World Trade

5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗

December 01, 2025

Via MarketBeat

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day? ↗

November 30, 2025

The comeback may have begun.

Via The Motley Fool

1 Nasdaq 100 Stock Worth Your Attention and 2 We Brush Off

November 25, 2025

The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing...

Via StockStory

Dow Jones Navigates Volatility Amidst AI Bubble Fears and Shifting Fed Expectations

November 25, 2025

The Dow Jones Industrial Average has been on a roller-coaster ride in November 2025, experiencing significant volatility and sending mixed signals across various sectors. While the index achieved a...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Dow Jones Navigates Choppy Waters: Rate Cut Hopes Clash with Valuation Fears

November 24, 2025

The Dow Jones Industrial Average (DJIA) has recently been a barometer of a market caught between conflicting forces, demonstrating significant daily fluctuations throughout November 2025. While the...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks

November 23, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q3, starting with BioMarin...

Via StockStory

Topics Artificial Intelligence

FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising ↗

November 20, 2025

FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.

Via Benzinga

Which S&P500 stocks are moving before the opening bell on Thursday? ↗

November 20, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.